» Articles » PMID: 28711960

Chronic Kidney Disease (CKD): An Observational Study of Etiology, Severity and Burden of Comorbidities

Overview
Specialty Pediatrics
Date 2017 Jul 17
PMID 28711960
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To study the etiology and burden of comorbidities across stages of chronic kidney disease (CKD).

Methods: Children, 2-16 y of age with CKD Stages II- IV were recruited over 12 mo. The etiology, clinical presentation and severity of complications were studied.

Results: Among 78 children [Stage II (n = 21), Stage III (n = 26), Stage IV (n = 31)], congenital anomalies of the kidney and urinary tract (CAKUT) was the commonest etiology and 28 were newly diagnosed in Stage III /IV. High prevalence of comorbidities was observed with growth retardation (65%), hypertension (59%), hyperphosphatemia (32%), vitamin D deficiency (92%), dyslipidemia (64%), left ventricular hypertrophy (45%) and hyperparathyroidism (56%). While most comorbidities correlated with the estimated glomerular filtration rate and severity of CKD, hypertension, vitamin D deficiency and cardiovascular morbidity were prevalent even in early stages.

Conclusions: CAKUT was the commonest cause of CKD. Late detection and high prevalence of comorbidities even in early stages of CKD were observed.

Citing Articles

Mind the gap in kidney care: translating what we know into what we do.

Luyckx V, Tuttle K, Abdellatif D, Correa-Rotter R, Fung W, Haris A Kidney Res Clin Pract. 2025; 44(1):6-19.

PMID: 39815796 PMC: 11838860. DOI: 10.23876/j.krcp.24.100.


Mind the gap in kidney care: Translating what we know into what we do.

Luyckx V, Tuttle K, Abdellatif D, Correa-Rotter R, Fung W, Haris A Nephrology (Carlton). 2025; 30(1):e14314.

PMID: 39789717 PMC: 11718150. DOI: 10.1111/nep.14314.


Prevalence and management of anemia and impact of treatment burden on health-related quality of life in chronic kidney disease and dialysis patients.

Khan A, Ghulam Hussain S, Mushtaq S, Abbas S, Dong Y, Feng W J Pharm Policy Pract. 2024; 17(1):2427779.

PMID: 39568794 PMC: 11578422. DOI: 10.1080/20523211.2024.2427779.


Economic burden of inpatient hospitalizations for pediatric chronic kidney disease in the US.

Taliwal N, Pandya A, Dixon A, Tibrewal A, Kumar R, Doshi K Pediatr Nephrol. 2024; 40(4):1059-1068.

PMID: 39508870 DOI: 10.1007/s00467-024-06568-2.


Ambulatory Hypertension in Children with Kidney Failure on Maintenance Dialysis.

Kamal S, Raj J, Pais P Indian J Nephrol. 2024; 34(5):503-505.

PMID: 39372634 PMC: 11450836. DOI: 10.25259/ijn_505_23.


References
1.
Copelovitch L, Warady B, Furth S . Insights from the Chronic Kidney Disease in Children (CKiD) study. Clin J Am Soc Nephrol. 2011; 6(8):2047-53. PMC: 4898858. DOI: 10.2215/CJN.10751210. View

2.
. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report):555-76. View

3.
Saland J, Pierce C, Mitsnefes M, Flynn J, Goebel J, Kupferman J . Dyslipidemia in children with chronic kidney disease. Kidney Int. 2010; 78(11):1154-63. PMC: 3222564. DOI: 10.1038/ki.2010.311. View

4.
Rajapurkar M, John G, Kirpalani A, Abraham G, Agarwal S, Almeida A . What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol. 2012; 13:10. PMC: 3350459. DOI: 10.1186/1471-2369-13-10. View

5.
Warady B, Chadha V . Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007; 22(12):1999-2009. PMC: 2064944. DOI: 10.1007/s00467-006-0410-1. View